We continue to favour AEM for its AI leveraged growth profile, underpinned by sustained tailwinds and ongoing diversification.
FY25 net profit came in at S$17.1mil (+48% y-o-y) on revenue of S$399.3mil (+5% y-o-y), above expectations.
- Read this at SGinvestors.io -
By segment, the test cell solutions business, which made up 63% of FY25 revenue, recorded 9% y-o-y growth on the back of successful production deployment and customer acceptance of AEM’s test solutions.
The contract manufacturing segment, contributing 35% of revenue, was flat despite softer end demand linked to global trade uncertainties. Net profit margin expanded 1.2 ppts to 4.3% given improved operating leverage as top line grew.
Resumption of dividends.
- Read this at SGinvestors.io -
The resumption of AEM's dividends at 1.3 Singapore cents for FY2025 (vs none in FY24) signals confidence in AEM’s turnaround.
Well positioned to benefit from multi year AI demand.
Read more at SGinvestors.io.
Above is an excerpt from a report by DBS Group Research. Clients of DBS may access the full PDF report @ https://www.dbs.com/insightsdirect/.
Use Trust referral code PGKPSWAE to sign up NTUC Link or Trust Link Credit Card or open a Trust Bank Savings Account: ✨Earn up to S$1,000 cashback rewards 🎟!